In the age of COVID-19, the last thing anyone wants is to schedule a doctor’s visit. Thanks to Noor Sweid’s Global Ventures, managing our health remotely is likely to get easier due to emerging market regional companies.
Global Ventures is now exploring opportunities in healthcare technology, with an eye on founders whose technologies are meeting increased demand for telemedicine and diagnostics in emerging markets in the wake of COVID-19.
Global Ventures most recent venture capital fund closed in December 2019 with $50 million. As of March, the fund’s capital was . . .
Continue Reading
Unlock this article instantly, along with the rest of our premium content and daily, weekly and monthly newsletters. We offer pay-as-you-go monthly subscriptions and discounted annual subscriptions with additional benefits: access to Alternatives Watch Research articles and our Annual Investor Compendium.
